Drugs, genes and screens: The ethics of preventing and treating spinal muscular atrophy

Spinal muscular atrophy (SMA) is the most common genetic disease that causes infant mortality. Its treatment and prevention represent the paradigmatic example of the ethical dilemmas of 21st‐century medicine. New therapies (nusinersen and AVXS‐101) hold the promise of being able to treat, but not cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyngell, Christopher, Stark, Zornitza, Savulescu, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318711/
https://www.ncbi.nlm.nih.gov/pubmed/31770817
http://dx.doi.org/10.1111/bioe.12695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318711/
https://www.ncbi.nlm.nih.gov/pubmed/31770817
http://dx.doi.org/10.1111/bioe.12695

Ejemplares similares